Kinaxis to Bolster Supply Chain Operations of Ono Pharmaceutical
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced Ono Pharmaceutical Co., Ltd.’s adoption of Kinaxis to help orchestrate full visibility and transparency across its global supply chain.
Ono Pharmaceutical Co., Ltd., (ONO) headquartered in Osaka, Japan, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. ONO focuses its research on oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. ONO has multiple subsidiaries and manufacturing facilities in Japan and overseas and is currently expanding its overseas business with the goal of a becoming a global specialty pharma.
Kinaxis Maestro™, the AI-infused supply chain orchestration platform, will drive operational efficiencies for ONO, empowering the company to expand and diversify its broad portfolio of life-saving drugs. The transformation comes at a time when ONO is preparing for an increase of direct sales in the US and Europe.
“Under the corporate philosophy ‘Dedicated to the Fight against Disease and Pain,’ ONO continues to contribute to and work toward the realization of a sustainable society through the generation of innovative drugs,” said Akira Takada, corporate executive officer, executive director, CMC & production at Ono Pharmaceutical Co., Ltd. “Kinaxis will play an important role in bolstering the supply chain efficiency required to ensure a stable delivery of medicines ONO creates across a broad range of therapeutic areas to patients worldwide.”
“The need for agility-driven transformation to meet challenges and drive business success is imperative in today’s uncertain world,” said Toshiya Kaneko, president at Kinaxis Japan. “With Kinaxis, ONO will be empowered to plan for any scenario, making them more resilient to whatever comes around the corner and bolstering their mission of delivering life-saving drugs to their patients.”
With the addition of ONO to its growing customer base, Kinaxis continues to cement its footprint within the life sciences industry, which provides the brand-name and generic medicines that countless patients rely on. Managing supply chain complexities in biotechnology, cell and gene therapy, medical devices, over-the-counter medicines and more, Kinaxis customers include some of the world's top pharma companies such as Dr. Reddy's, Jamieson Wellness, Merck, Novartis, Siemens Healthineers and Servier.
To learn more about Kinaxis and its supply chain management solutions, please visit Kinaxis.com.
About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ , combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241007501185/en/
Contacts
Media Relations
Jaime Cook | Kinaxis
jcook@kinaxis.com
289-552-4640
Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Coca-Cola Company Names New Leader for Europe Operating Unit18.7.2025 22:00:00 EEST | Press release
The Coca-Cola Company today announced that Luisa Ortega will become president of the Europe operating unit effective Sept. 1, succeeding Nikos Koumettis, who will retire in 2026 after a 25-year career with the company. Koumettis will remain with the company through Feb. 28, 2026, as a senior advisor. He will also serve on the board of directors of Hindustan Coca-Cola Beverages Pvt. Ltd., a company-owned bottler in India. Ortega joined Coca-Cola in 2019 and currently serves as president of the Africa operating unit. In this role, she leads a complex business that operates across 54 markets. Koumettis has led the Europe operating unit since it was created in 2021. “Luisa has done an outstanding job leading our African business, where our system has continued to make major investments to serve growing markets on the continent,” said Henrique Braun, Executive Vice President and Chief Operating Officer of The Coca-Cola Company. “As head of Europe, she will bring great international experien
NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador18.7.2025 16:00:00 EEST | Press release
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced Baltimore Ravens running back Derrick Henry as the newest elite athlete to join its growing roster of ambassadors. Known for his rare combination of speed and strength, Henry will utilize Amazfit wearables to power every phase of his training, recovery and sleep as he prepares for his 10th NFL season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250718322498/en/ Derrick Henry is the newest elite athlete to join Amazfit's growing roster of ambassadors. As one of the most prolific running backs of his generation, Henry has amassed an impressive array of accolades during his career, including NFL Offensive Player of the Year, two rushing titles, and five Pro Bowl selections. With Amazfit as his official smart wearable partner, the former Heisman winner will integrate advanced health and fitness tracking into his training regimen and r
Qualcomm Announces Quarterly Cash Dividend18.7.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on September 25, 2025, to stockholders of record at the close of business on September 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensin
MultiBank Group Confirms $MBG Token Listings on MEXC and Gate.io on TGE Day in Addition to MultiBank.io and Uniswap18.7.2025 15:34:00 EEST | Press release
MultiBank Group, the world’s largest & most regulated financial derivatives institution, is proud to announce that its highly anticipated $MBG Token will be listed on two new major global cryptocurrency exchanges — MEXC and Gate.io — on the day of its official Token Generation Event (TGE), July 22, 2025, in addition to MultiBank.io and Uniswap. The $MBG Token will go live on: MultiBank.ioGate.ioMEXCUniswap This new dual listing will allow millions of users across both exchanges to seamlessly access and trade $MBG using their existing accounts, ensuring immediate market participation at launch. The Token Generation Event (TGE) is now approaching following the successful completion of two pre-sale rounds, where MultiBank Group issued 7 million tokens in Round 1 and 3 million tokens in Round 2 — both of which sold out within minutes. Naser Taher, Chairman and Founder of MultiBank Group said “With $MBG, we’re introducing a utility token built to deliver real-world value, transparency, and
SLB Announces Second-Quarter 2025 Results18.7.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the second-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716727689/en/ The exterior of the SLB headquarters in Houston, Texas. Second-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2025Mar. 31, 2025Jun. 30, 2024SequentialYear-on-yearRevenue $8,546 $8,490 $9,139 1% -6% Income before taxes - GAAP basis $1,285 $1,063 $1,421 21% -10% Income before taxes margin - GAAP basis 15.0% 12.5% 15.5% 251 bps -52 bps Net income attributable to SLB - GAAP basis $1,014 $797 $1,112 27% -9% Diluted EPS - GAAP basis $0.74 $0.58 $0.77 28% -4% Adjusted EBITDA* $2,051 $2,020 $2,288 2% -10% Adjusted EBITDA margin* 24.0% 23.8% 25.0% 21 bps -103 bps Pretax segment operating income* $1,584 $1,556 $1,854 2% -15% Pretax segment operating margin* 18.5% 18.3% 20.3% 20 bps -175 bps Net income attributable to SLB, excluding charges & credits* $1,016
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom